Abstract
Chlorotoxin, or TM-601, is a peptide derived from the venom of the scorpionLeiurus Quinquestriatus that specifically binds to malignant brain tumors, but not to normal tissues. Targeted radiotherapy using 131I-Chlorotoxin is promising for post-surgery treatment of brain tumors. This study reports dosimetry results of 131I-Chlorotoxin in athymic nude mice with intracranially implanted human glioma xenografts and projected radiation doses in patients receiving 370 MBq of 131I-Chlorotoxin. 125I/131I-Chlorotoxin were injected into the right brain where D54 MG xenografts were implanted. Mice were sacrificed 24–96 h later. The blood, normal organs, and tumors were weighed and counted to determine 131I-Chlorotoxin concentration. The radiation dose from 131I was calculated based on non-penetrating radiation in the mouse model. Assuming similar tissue uptake in mice and patients, radiation doses for patients were extrapolated. Distributions of 125I/131I-Chlorotoxin were only significant in tumor, stomach, kidneys, and brain (injection site), reflecting non-specific uptake of Chlorotoxin in normal tissues. Mean radiation dose (cGy/37 kBq) was 58.2 for tumor, 17.9 for brains, 1.8 for marrow, 27.1 for stomach, 16.0 for kidneys in mice. For intracranial injection of 370 MBq 131I-Chlorotoxin in patients, extrapolated patient dose (cGy) was 70 for brains, 6 for marrow, 35 for stomach, 60 to kidneys, 227 to tumor, suggesting that 3.7 GBq of 131I-Chlorotoxin can be safely administrated to patients. These promising results demonstrated potential in improving patient survival using this novel targeting agent.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
MW McDermott PK Sneed PH Gutin (1998) ArticleTitleInterstitial brachytherapy for malignant brain tumors Semin Surg Oncol 14 79–87
JN Sarkaria MP Mehta JS Loeffler JM Buatti RJ Chappell AB Levin E III Alexander WA Friedman TJ Kinsella (1995) ArticleTitleRadiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis.Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32 931–941
SA Lyons J O’Neal H Sontheimer (2002) ArticleTitleChlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin GLIA 39 162–173
L Soroceanu Y Gillespie MB Khazaeli H Sontheimer (1998) ArticleTitleUse of chlorotoxin for targeting of primary brain tumors Cancer Res 58 4871–4879
J Deshane CC Garner H Sontheimer (2003) ArticleTitleChlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 J Biol Chem 278 4135–4144
WH Ellett RM Humes (1971) ArticleTitleAbsorbed fractions for small volumes containing photon-emitting radioactivity. J Nucl Med 12 25–32
R Loevinger M Bermam (1976) A Revised Schema for Calculating the Absorbed Dose from Biologically Distributed Radionuclides. MIRD Pamphlet No.1. Society of Nuclear Medicine New York
S Shen GL Denardo G Sgouros RT O’Donnell SJ Denardo (1999) ArticleTitlePractical determination of patient-specific marrow dose using radioactivity concentration in blood and body J Nucl Med 40 2102–2106
AS Kirschner R Ice W Beierwaltes (1975) ArticleTitleRadiation dosimetry of I-131-iodocholesterol: the pitfalls of using tissue concentration data–Author’s reply J Nucl Med 16 248–249
WS Snyder MR Ford GG Warner SB Watson (1975) ‘S’Absorbed Dose Per Unit Cumulated Activity for Selected Radionuclides and Organs. MIRD Pamphlet No. 11. Society of Nuclear Medicine New York
TE Hui DR Fisher JA Kuhn LE Williams C Nourigat CC Badger BG Beatty JD Beatty (1994) ArticleTitleA mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates Cancer 73 951–957
P Riva A Arista C Sturiale G Moscatelli V Tison M Mariani E Seccamani S Lazzari L Fagioli G Franceschi et al. (1992) ArticleTitleTreatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2 Int J Cancer 51 7–13 Occurrence Handle1:STN:280:By2B38rmvFI%3D Occurrence Handle1373410
G Paganelli M Bartolomei M Ferrari M Cremonesi G Broggi G Maira C Sturiale C Grana G Prisco M Gatti P Caliceti M Chinol (2001) ArticleTitlePre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results Cancer Biother Radiopharm 16 227–235
DD Bigner MT Brown AH Friedman RE Coleman G Akabani HS Friedman WL Thorstad RE McLendon SH Bigner XG Zhao CN Pegram CJ Wikstrand JE Herndon NA Vick N Paleologos I Cokgor JM Provenzale MR Zalutsky (1998) ArticleTitleIodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results J Clin Oncol 16 2202–2212 Occurrence Handle1:CAS:528:DyaK1cXktV2isbc%3D Occurrence Handle9626222
S Venturi M Venturi (1999) ArticleTitleIodide, thyroid and stomach carcinogenesis: evolutionary story of a primitive antioxidant Eur J Endocrinol 140 371–372
B Emami J Lyman A Brown L Coia M Goitein JE Munzenrider B Shank LJ Solin M Wesson (1991) ArticleTitleTolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 109–122 Occurrence Handle1:STN:280:By6B3snkslI%3D Occurrence Handle2032882
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shen, S., Khazaeli, M.B., Gillespie, G.Y. et al. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice. J Neurooncol 71, 113–119 (2005). https://doi.org/10.1007/s11060-004-0890-4
Issue Date:
DOI: https://doi.org/10.1007/s11060-004-0890-4